
Adjuvant radiotherapy (ART) reduces locoregional recurrence in completely resected BWH T2b/T3 cutaneous squamous cell carcinomas by approximately 50
Pityriasis Lichenoides Chronica (PLC) and Pityriasis Lichenoides et Varioliformis Acuta (PLEVA) are rare conditions characterized by inflammatory skin lesions with unclear etiology [1, 2]. Treatment therapies include antibiotics, steroids, methotrexate, and phototherapy [1, 3–5]. This retrospective study describes azithromycin use, treatment outcomes, and documented adverse events in pediatric patients with pityriasis lichenoides and descriptively compares these findings with patients receiving other therapies. Among 54 patients, 13 received azithromycin and 41 received other treatments, no significant difference in physician-documented treatment response or adverse events was detected, while azithromycin was administered less frequently than most other treatments.
Bullous pemphigoid (BP) is an autoimmune subepidermal blistering disease characterized by autoantibody-mediated inflammation, yet its systemic metabolic alterations remain incompletely understood. In this study, we performed comprehensive serum metabolomic profiling of BP patients and healthy controls using ultra-high-performance liquid chromatography coupled with high-resolution mass spectrometry. Among 4288 detected metabolites, partial least squares-discriminant analysis revealed clear separation between the two groups, and 452 metabolites showed significant differential abundance. These metabolites were mainly related to carbohydrates, lipids, amino acids, and nucleotides. The altered metabolites were mainly distributed among carbohydrates, lipids, amino acids, and nucleotides. Pathway enrichment analysis identified coordinated perturbations in central energy metabolism, including glycolysis/gluconeogenesis, the pentose phosphate pathway, and the tricarboxylic acid cycle, as well as sulfur-containing amino acid metabolism, glutathione-related pathways, and lipid remodeling. Network-level analysis further showed decreased abundance of multiple glycolytic and TCA-cycle intermediates, broad remodeling of lysophospholipids, membrane phospholipids, and sphingolipid-associated signaling. These findings indicate that BP is associated with broad serum metabolic reprogramming involving energy metabolism, redox homeostasis, amino acid metabolism, and lipid signaling. Given the exploratory design and the limited availability of detailed clinical covariates, the present findings should be interpreted as hypothesis-generating rather than causal. This study provides a systematic serum metabolomic overview of BP and identifies candidate metabolic pathways for future mechanistic and biomarker-validation studies.